Dina Ramadane
Stock Analyst at Bank of America Securities
(2.24)
# 3,028
Out of 4,587 analysts
17
Total ratings
66.7%
Success rate
3.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dina Ramadane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics | Reiterated: Buy | $65 → $70 | $33.05 | +111.80% | 7 | Jul 7, 2026 | |
| BHVN Biohaven | Downgraded: Sell | $12 → $11 | $13.82 | -20.41% | 7 | Jun 29, 2026 | |
| PROK ProKidney | Reiterated: Sell | $1 | $1.58 | -36.71% | 2 | May 18, 2026 | |
| IMVT Immunovant | Reiterated: Buy | $32 | $39.48 | -18.95% | 1 | Feb 6, 2026 |
Vera Therapeutics
Jul 7, 2026
Reiterated: Buy
Price Target: $65 → $70
Current: $33.05
Upside: +111.80%
Biohaven
Jun 29, 2026
Downgraded: Sell
Price Target: $12 → $11
Current: $13.82
Upside: -20.41%
ProKidney
May 18, 2026
Reiterated: Sell
Price Target: $1
Current: $1.58
Upside: -36.71%
Immunovant
Feb 6, 2026
Reiterated: Buy
Price Target: $32
Current: $39.48
Upside: -18.95%